In a SOD1Gly93Ala rat model of ALS, it was shown that onset of paralysis was delayed by 17 days, improved motor performance, and extended lifespan by 22 days due to intracerebroventricular (i.c.v.)delivery of recombinant (VEGF). This evidence concerns the gene VEGFA and amyotrophic lateral sclerosis.